| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.96▲ | 6.18▼ | 6.20▼ | 5.92▼ | 5.15▲ |
| MA10 | 6.11▼ | 6.30▼ | 6.21▼ | 6.00▼ | 4.74▲ |
| MA20 | 6.25▼ | 6.19▼ | 6.11▼ | 5.44▲ | 4.93▲ |
| MA50 | 6.13▼ | 6.05▼ | 6.16▼ | 4.82▲ | 7.96▼ |
| MA100 | 6.14▼ | 6.00▼ | 5.38▲ | 5.08▲ | 9.60▼ |
| MA200 | 5.83▲ | 5.28▲ | 5.08▲ | 7.56▼ | 16.85▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.054▼ | -0.042▼ | -0.025▼ | 0.008▲ | 0.386▲ |
| RSI | 40.067▼ | 43.621▼ | 47.309▼ | 54.302▲ | 50.102▲ |
| STOCH | 9.854▼ | 44.475 | 50.045 | 26.051 | 34.940 |
| WILL %R | -84.615▼ | -84.615▼ | -78.571▼ | -73.402 | -58.697 |
| CCI | -61.106 | -121.624▼ | -55.053 | 19.325 | 126.019▲ |
|
Tuesday, December 09, 2025 07:39 AM
Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its burixafor combination in multiple myeloma.
|
|
Tuesday, December 09, 2025 07:16 AM
Exicure, a clinical-stage biotechnology company specializing in next-generation stem-cell mobilization therapies, has staged a massive rally.
|
|
Thursday, September 11, 2025 09:37 PM
(RTTNews) - Several biotech stocks made sharp moves in after-hours trading on Thursday, September 11, 2025, driven by clinical updates, strategic pivots, and rebranding efforts. Here's a quick look at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/12/25 | 6.10 | 6.56 | 5.80 | 5.92 | 159,719 |
| 18/12/25 | 5.85 | 6.25 | 5.85 | 6.09 | 91,844 |
| 17/12/25 | 6.14 | 6.261 | 5.80 | 5.81 | 69,109 |
| 16/12/25 | 5.70 | 6.32 | 5.63 | 6.06 | 181,800 |
| 15/12/25 | 6.25 | 6.25 | 5.72 | 5.73 | 157,217 |
| 12/12/25 | 5.85 | 6.55 | 5.6001 | 6.35 | 216,090 |
| 11/12/25 | 5.15 | 6.8938 | 5.145 | 6.07 | 559,006 |
| 10/12/25 | 6.34 | 6.42 | 5.2701 | 5.32 | 1,103,198 |
| 09/12/25 | 9.16 | 9.4799 | 6.91 | 7.29 | 30,269,694 |
| 08/12/25 | 4.87 | 5.45 | 4.87 | 5.33 | 4,183,934 |
|
|
||||
|
|
||||
|
|